State-Level Estimates of the Prevalence of Parent-Reported ADHD Diagnosis and Treatment Among U.S. Children and Adolescents, 2016 to 2019

Objective: To provide state-level estimates of diagnosed ADHD and associated treatment among children in the United States in 2016 to 2019. Method: This study used the National Survey of Children’s Health to produce national and state-level estimates of lifetime diagnosis and current ADHD among all children aged 3 to 17 years (n=114,476), and national and state-level estimates of medication and behavioral treatment use among children with current ADHD. Results: The state-level estimates of diagnosed ADHD ranged from 6.1% to 16.3%. Among children with current ADHD, state-level estimates of ADHD medication usage ranged from 37.8% to 81.4%, and state-level estimates of behavioral treatment ranged from 38.8% to 61.8%. Conclusion: There was substantial state-level variation for indicators of ADHD diagnosis and associated treatment. These state-level results can be used by policymakers, public health practitioners, health care providers, and other stakeholders to help address the service needs of children with ADHD in their states.

[1]  D. Brody,et al.  Mental Health Surveillance Among Children — United States, 2013–2019 , 2022, MMWR supplements.

[2]  Goran Bozinovic,et al.  U.S. national, regional, and state-specific socioeconomic factors correlate with child and adolescent ADHD diagnoses pre-COVID-19 pandemic , 2021, Scientific Reports.

[3]  Sowmya R. Rao,et al.  Therapy use for U.S. school-aged children with developmental disabilities: State variation and determinants. , 2021, Disability and health journal.

[4]  E. Schor,et al.  Child Health Inequities Among State Medicaid Programs. , 2021, JAMA pediatrics.

[5]  K. B. Franke,et al.  Building Policy Support for School Mental Health in South Carolina , 2020 .

[6]  Christopher M. Jones,et al.  Trends in stimulant dispensing by age, sex, state of residence, and prescriber specialty - United States, 2014-2019. , 2020, Drug and alcohol dependence.

[7]  N. Serban,et al.  Provider-Level Caseload of Psychosocial Services for Medicaid-Insured Children , 2020, Public health reports.

[8]  W. Canu.  ADHD in North Carolina , 2020, North Carolina Medical Journal.

[9]  Stephen G. Henry,et al.  Age- and Sex-Specific Increases in Stimulant Prescribing Rates—California, 2008-2017 , 2020, Journal of attention disorders.

[10]  William B. Vogt,et al.  Growth and Distribution of Child Psychiatrists in the United States: 2007–2016 , 2019, Pediatrics.

[11]  Christoph U. Lehmann,et al.  Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents , 2019, Pediatrics.

[12]  M. Peterson,et al.  US National and State-Level Prevalence of Mental Health Disorders and Disparities of Mental Health Care Use in Children , 2019, JAMA pediatrics.

[13]  B. Ward.  kg_nchs: A command for Korn-Graubard confidence intervals and National Center for Health Statistics' Data Presentation Standards for Proportions. , 2017, The Stata journal.

[14]  M. Gleason,et al.  Pediatric Attention-Deficit/Hyperactivity Disorder in Louisiana: Trends, Challenges, and Opportunities for Enhanced Quality of Care , 2019, Ochsner Journal.

[15]  2018 National Survey of Children’s Health , 2019 .

[16]  B. Piper,et al.  Trends in use of prescription stimulants in the United States and Territories, 2006 to 2016 , 2018, PloS one.

[17]  M. Silverstein,et al.  The Value of State Differences in Autism When Compared to a National Prevalence Estimate , 2018, Pediatrics.

[18]  Jessica R. Jones,et al.  The Design and Implementation of the 2016 National Survey of Children’s Health , 2018, Maternal and Child Health Journal.

[19]  D. Patterson,et al.  Geographic Variation in the Supply of Selected Behavioral Health Providers. , 2018, American journal of preventive medicine.

[20]  M. Morrill.  Special Education Financing and ADHD Medications: A Bitter Pill to Swallow. , 2018 .

[21]  Stephen J. Blumberg,et al.  Prevalence of Parent-Reported ADHD Diagnosis and Associated Treatment Among U.S. Children and Adolescents, 2016 , 2018, Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53.

[22]  2016 National Survey of Children’s Health , 2018 .

[23]  S. Visser,et al.  Medicaid Prior Authorization Policies for Medication Treatment of Attention-Deficit/Hyperactivity Disorder in Young Children, United States, 2015 , 2017, Public health reports.

[24]  J. Pell,et al.  Educational and Health Outcomes of Children Treated for Attention-Deficit/Hyperactivity Disorder , 2017, JAMA pediatrics.

[25]  T. Brennan,et al.  Association Between Academic Medical Center Pharmaceutical Detailing Policies and Physician Prescribing , 2017, JAMA.

[26]  Elizabeth B. Owens,et al.  Functional Adult Outcomes 16 Years After Childhood Diagnosis of Attention-Deficit/Hyperactivity Disorder: MTA Results. , 2016, Journal of the American Academy of Child and Adolescent Psychiatry.

[27]  James G. Scott,et al.  Long-Term Outcomes of Attention-Deficit/Hyperactivity Disorder and Conduct Disorder: A Systematic Review and Meta-Analysis. , 2016, Journal of the American Academy of Child and Adolescent Psychiatry.

[28]  M. Wolraich,et al.  Vital Signs: National and State-Specific Patterns of Attention Deficit/Hyperactivity Disorder Treatment Among Insured Children Aged 2-5 Years - United States, 2008-2014. , 2016, MMWR. Morbidity and mortality weekly report.

[29]  Subcommittee on Attention-Deficit/Hyperactivity Disorder , 2016, Pediatric Clinical Practice Guidelines & Policies.

[30]  Steering Committee on Quality Improvement and Management , 2016, Pediatric Clinical Practice Guidelines & Policies.

[31]  L. Schieve,et al.  Treatment of Attention Deficit/Hyperactivity Disorder among Children with Special Health Care Needs. , 2015, The Journal of pediatrics.

[32]  Brent D. Fulton,et al.  State Variation in Increased ADHD Prevalence: Links to NCLB School Accountability and State Medication Laws. , 2015, Psychiatric services.

[33]  Jan K. Buitelaar,et al.  Attention-deficit/hyperactivity disorder , 2015, Nature Reviews Disease Primers.

[34]  M. Kogan,et al.  Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003-2011. , 2014, Journal of the American Academy of Child and Adolescent Psychiatry.

[35]  D. Mcdonald,et al.  Geographic variation and disparity in stimulant treatment of adults and children in the United States in 2008. , 2013, Psychiatric services.

[36]  R. Perou,et al.  Convergent validity of parent-reported attention-deficit/hyperactivity disorder diagnosis: a cross-study comparison. , 2013, JAMA pediatrics.

[37]  M. Kogan,et al.  State-Based and Demographic Variation in Parent-Reported Medication Rates for Attention-Deficit/Hyperactivity Disorder, 2007–2008 , 2013, Preventing chronic disease.

[38]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[39]  Farasat A. S. Bokhari,et al.  School accountability laws and the consumption of psychostimulants. , 2011, Journal of health economics.

[40]  Marian Earls,et al.  ADHD : Clinical Practice Guideline for the Diagnosis , Evaluation , and Treatment of Attention-Deficit / Hyperactivity Disorder in Children and Adolescents , 2011 .

[41]  R. Perou,et al.  Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children --- United States, 2003 and 2007. , 2010, MMWR. Morbidity and mortality weekly report.

[42]  Brent D. Fulton,et al.  National variation of ADHD diagnostic prevalence and medication use: health care providers and education policies. , 2009, Psychiatric services.

[43]  S. Pliszka,et al.  Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. , 2007, Journal of the American Academy of Child and Adolescent Psychiatry.

[44]  D. Alice,et al.  Attention deficit hyperactivity disorder (ADHD). , 1991, Journal of child neurology.